Cutaneous Sebaceous Neoplasms with a Focal Glandular Pattern (Seboapocrine Lesions): a Clinicopathological Study of Three Cases Dmitry V

Total Page:16

File Type:pdf, Size:1020Kb

Cutaneous Sebaceous Neoplasms with a Focal Glandular Pattern (Seboapocrine Lesions): a Clinicopathological Study of Three Cases Dmitry V ORIGINAL ARTICLE Cutaneous Sebaceous Neoplasms With a Focal Glandular Pattern (Seboapocrine Lesions): A Clinicopathological Study of Three Cases Dmitry V. Kazakov, MD, PhD,* Eduardo Calonje, MD,† Dip RCPath, Arno Ru¨tten, MD,‡ Kathrin Glatz, MD,§ and Michal Michal, MD* sebaceous differentiation and different architectural and Abstract: Presented here are three cutaneous sebaceous tumors cytological features, usually allowing clear histopathological (one carcinoma and two sebaceomas), each demonstrating a focal separation, although some histopathological overlap exists. glandular pattern representing apocrine differentiation. The patients, The tumor cells in these sebaceous neoplasms grow mainly in two males and one female, each clinically presented with a small a cohesive fashion, although rare tumors manifest distinctive solitary nodule or tumor on the scalp. None of the patients had growth patterns such as the rippled, labyrinthine/sinusoidal, features of Muir–Torre syndrome. Surgical removal of the lesions was and carcinoid-like ones that are apparently specific for lesions performed in all cases. None of the patients developed recurrence or with sebaceous differentiation and are encountered either sin- metastasis after surgery (follow-up ranged from 18 to 24 months). gly or in combination in cutaneous tumors with sebaceous The glandular areas represented a minor but significant component of differentiation.2–6 So-called adenoid and acinar patterns have the lesions and appeared as glands of various complexity, mostly as been recorded in some examples of ocular sebaceus carcinoma,7 simple round or elongated tubular structures lined by a row of and rare sebaceous neoplasms have been reported to focally cuboidal to columnar cells with eosinophilic cytoplasm and round exhibit apocrine differentiation.8,9 Presented here are three nuclei, with or without a distinct nucleolus. Decapitation secretion further cutaneous sebaceous tumors with a focal glandular was evident but not prominent. In both sebaceomas, at least a portion pattern representing apocrine differentiation. of the glands had a peripheral small-cell layer that appeared similar to the basal/myoepithelial cells of normal eccrine and apocrine ducts. In some glands, the basal/myoepithelial cells seemed to have undergone hyperplasia, resulting in two or more rows of cells that even formed MATERIALS AND METHODS small islands, with an overall appearance reminiscent of basal cell Histological slides from approximately 200 malignant hyperplasia in the prostate, arising in the basal layer of the prostatic and benign cutaneous sebaceous tumors (ocular and extra- glands. The descriptive terms seboapocrine carcinoma or seboapo- ocular carcinomas, sebaceomas, sebaceous adenomas, basal crine sebaceoma are proposed for such lesions. These tumors may be cell carcinoma with sebaceous differentiation, cystic seba- ceous tumor10), including those associated with the Muir– viewed as rare histopathological variants of sebaceous carcinoma and 11 sebaceoma, with a second type of differentiation along the lines of the Torre syndrome, were evaluated. Cases of organoid nevus folliculosebaceous–apocrine unit. (nevus sebaceus of Jadassohn) and secondary tumors arising in it were not studied and, when recognized histologically as Key Words: adnexal tumors, sebaceous neoplasms, apocrine such, were excluded. Eight sebaceous tumors manifesting differentiation, multidirectional differentiation, myoepithelial cells a glandular pattern were found. The term glandular is used to (Am J Dermatopathol 2007;29:359–364) describe structures containing lumina surrounded by epithelial cells, with or without evidence of decapitation secretion. Multiple sections were reviewed to exclude the possibility that these glandular areas might represent preexisting ducts or ebaceous tumors of the skin are most commonly classified represent a pseudoglandular pattern attributable to various Sinto carcinoma (ocular and extraocular), sebaceoma, and causes (holocrine secretion, cell discohesive arrangement 1 sebaceous adenoma. These show different degrees of attributable to necrosis, acantholysis, or myxoid degeneration), as was the case in five tumors that were subsequently excluded from the study. Clinical information and follow-up on the three From the *Sikl’s Department of Pathology, Charles University, Medical included cases were obtained from pathology reports, sub- Faculty Hospital, Pilsen, Czech Republic (D.V.K.,M.M.); †Department of Dermatopathology, St John’s Institute of Dermatology, St Thomas’s mitting pathologists, patients, and their clinicians. Hospital, London, England, UK (E.C.); ‡Dermatohistopathologische Paraffin blocks or reserved unstained slides were Gemeinschaftspraxis, Friedrichshafen, Germany (A.R.); and §Institute of available in two cases for immunohistochemical study. Pathology, University of Basel, Basel, Switzerland (K.G.). Immunohistochemical stains were performed on 5-mM-thick, Reprints: Dmitry V. Kazakov, MD, PhD, Sikl’s Department of Pathology, Charles University Medical Faculty Hospital, Alej Svobody 80, 304 60 formalin-fixed, paraffin-embedded tissue sections, and appro- PILSEN, Czech Republic (e-mail: [email protected]). priate controls were applied using the monoclonal and poly- Copyright Ó 2007 by Lippincott Williams & Wilkins clonal antisera listed in Table 1. The avidin–biotin complex or Am J Dermatopathol Volume 29, Number 4, August 2007 359 Kazakov et al Am J Dermatopathol Volume 29, Number 4, August 2007 complexity, mostly as simple round or elongated tubular TABLE 1. Antibodies Used for Immunohistochemical Study structures lined by rows of cuboidal to columnar cells with Antibody Specificity Clone Dilution Source eosinophilic cytoplasm and round nuclei, with or without a CK7 OV-TL 12/30 1:200 DakoCytomation distinct nucleolus (Fig. 1E and F and Fig. 2D–F). Decapitation CK 14 Ll002 1:1000 NeoMarkers secretion was evident but not prominent (Fig. 2E). In one EMA E29 1:700 DakoCytomation sebaceoma (case 3), the cytoplasm of the luminal cells in CK 8 &18 CAM5.2 1:200 Becton Dickinson glandular structures contained zymogen granules (Fig. 2F). ASMA 1A4 1:200 DakoCytomation In both sebaceomas, at least a portion of the glands had a MSA HHF-35 1:5000 DakoCytomation peripheral small-cell layer that seemed similar to the basal/ GCDFP-15 BRST-2 1:1000 Signet Laboratories myoepithelial cells of normal eccrine and apocrine ducts. The p63 4A4 1:500 Biotex gland structures were numerous and were distributed some- CK, cytokeratin; EMA, epithelial membrane antigen; ASMA, a-smooth muscle what haphazardly. In some glands, the basal/myoepithelial actin; MSA, muscle-specific actin; GCDFP-15, gross cystic disease fluid protein-15. cells seemed to have undergone hyperplasia, resulting in two or more rows of cells that even formed small islands, with an overall appearance reminiscent of basal cell hyperplasia in streptavidin–biotin complex, labeled with peroxidase or the prostate, arising in the basal layer of the prostatic glands. alkaline phosphatase, were employed as the detection systems. (Fig. 2G). Glands with basal/myoepithelilal cells and those Automated immunostaining employing the Lab Vision lacking them were intermingled. automatic stainer was used. In one sebaceoma (case 2), there were foci of immature squamous metaplasia and areas composed of basaloid cells, devoid of sebaceous differentiation, that housed scattered RESULTS lymphocytes, with the resulting picture vaguely resembling a spiradenoma. In both sebaceomas, differentiation toward Clinical Data sebaceous ducts was seen. No other metaplastic phenomena or The patients, two males and one female, each clinically adnexal-type differentiations were observed, nor were there presented with a small solitary nodule or tumor on the scalp any recognizable microscopic features of nevus sebaceus of (Table 2). Ulceration was seen in case 1, which represented Jadassohn. sebaceous carcinoma. None of the patients had features of Muir–Torre syndrome. Surgical removal of the lesions was Immunohistochemical Findings performed in all cases. None of the patients developed Immunohistochemical studies were performed on the recurrence or metastasis after surgery (follow-up ranged from sebaceomas. The glandular areas were positive for CAM5.2 18 to 24 months). and CK7 (Fig. 2H). Stains for CK7 also highlighted sebocytes with multivacuolated cytoplasm, as did the stains for EMA Histopathological Findings (Fig. 2I). CK14 stained the entire tumors, including the One case was classified as sebaceous carcinoma because glandular parts and basaloid cells; GCDFP-15 was tested in of the presence of architectural (asymmetry, infiltrative case 3 and proved positive in the glandular luminal cells. The growth) and cytological atypia (cellular and nuclear pleomor- peripheral basal/myoepithelial-like cells in the glandular areas phism, cell necrosis, atypical mitoses; Fig. 1A–D). Two were positive for p63 in both cases; they tested negative for lesions were classified as sebaceomas (Fig. 2A–C). All three actins in case 3. neoplasms manifested a multinodular architecture and were predominantly composed of basaloid cells and cells with vacuolated cytoplasm and scalloped nuclei. The neoplasm DISCUSSION cells grew mainly in a cohesive fashion, but in both seba- We have presented three sebaceous cutaneous neo- ceomas, labyrinthine/sinusoidal, poorly developed carcinoid- plasms with a focal glandular pattern. The detection of this like, and rippled patterns, as previously reported,2–4 were
Recommended publications
  • Malignant Eccrine Adenoma with Sarcomatous (Heterologous) Components: Report of a Rare Skin Adnexal Neoplasm with Literature Review
    Open Access Case Report DOI: 10.7759/cureus.12390 Malignant Eccrine Adenoma With Sarcomatous (Heterologous) Components: Report of a Rare Skin Adnexal Neoplasm With Literature Review Hira Ishtiaq 1 , Muhammad Abdulwaasey 1 , Muhammad Usman Tariq 1 , Saira Fatima 2 1. Histopathology, Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, PAK 2. Histopathology, Aga Khan University Hospital, Karachi, PAK Corresponding author: Muhammad Usman Tariq, [email protected] Abstract Malignant eccrine spiradenoma (MES) is an exceedingly rare skin adnexal tumor that arises from pre- existing benign eccrine spiradenoma (BES). MES tumors show a wide spectrum of morphological features, posing a diagnostic challenge to the pathologist. Sarcomatous (heterologous) elements are seen in a few of these tumors, further complicating the morphological picture. We herein describe a case of a 66-year-old male who presented with a recently enlarging, ulcerated, nodular skin lesion over the right leg that had been present for the last 25 years. The patient underwent wide local excision of the tumor. Microscopic examination revealed a neoplastic lesion comprising benign and malignant components. The carcinomatous component showed features of infiltrating adenocarcinoma, not otherwise specified, whereas the sarcomatous component showed predominant osteosarcomatous and focal chondrosarcomatous differentiation. The benign component showed morphological and immunohistochemical features of BES. No adjuvant treatment was administered. The patient was alive and disease-free for 14 months, after which he was lost to follow-up. Careful identification and knowledge related to histological diversity are keys to the correct diagnosis of this rare tumor. MESs are potentially aggressive tumors, and therefore, close long-term follow-up should be maintained.
    [Show full text]
  • Sample Research Poster
    Surgical management and lymph node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients Amrita Goyal MD, 1 Theodore Marghitu,2 Nikhil Goyal BS,3 Nathan Rubin MS,4 Krishnan Patel MD,6 Kavita Goyal MD,1 Daniel O’Leary MD,5 Kimberly Bohjanen MD, 1 Ian Maher MD 1 1Department of Dermatology, University of Minnesota, Minneapolis, MN 2University of Minnesota Medical School, Minneapolis, MN 3National Institutes of Health/National Cancer Institute, Bethesda, MD 4Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis MN 5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 6Department of Radiation Oncology, University of Minnesota, Minneapolis, MN Background Overall and Disease-Specific Survival Lymph Node Biopsy and Survival Cutaneous adnexal carcinomas comprise a group of Vital status* All Sweat Hidradenocarc Spiradenocarci Sclerosin Porocarcin Eccrine Sebaceous Lymph Nodes All adnexal tumors adnexal gland inoma noma g sweat oma adenocarci carcinoma Lymph Nodes Examined carcino duct noma Nodes not examined 6592 (91.9) rare cutaneous malignancies that are generally ma tumor Nodes examined 578 (8.1) (MAC) Positive (% of examined) 138 (23.9) considered non-aggressive. Guidelines for the Stage (Derived AJCC N=1863 N=70 N=127 N=46 N=236 N=229 N=187 N=968 Negative (% of examined) 440 (76.1) Stage Group, 6th ed treatment of many of these malignancies are sparse, (2004-2015) Total N=1221 5-year OS 5-year DSS 1,2 I 1221 40 (57.1) 56 (44.1) 14 (30.4) 150 140 (61.1) 103 (55.1) 718 (74.2) Stage I Examined N=112 including guidance on surgical management (65.5) (63.6) Nodes not examined (% of total) 1109 (90.8) 69.7 (66.1-72.4) 99.3 (99.6-100) 3,4 II 440 14 (20.0) 54 (47.5) 28 (60.9) 47 (19.9) 64 (27.9) 51 (27.3) 182 (18.8) Nodes positive (% of examined) 0 (0) -- -- including the utility of lymph node biopsy.
    [Show full text]
  • An Aggressive Treatment for Aggressive Digital Papillary Adenocarcinoma
    Continuing Medical Education An Aggressive Treatment for Aggressive Digital Papillary Adenocarcinoma H. Serhat Inaloz, MD, MSc; G.K. Patel, MRCP; Arthur G. Knight, MD, FRCP GOAL To recognize the clinical and histologic signs of aggressive digital papillary adenoma (ADPA) and adenocarcinoma (ADPAca) OBJECTIVES Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Recognize the symptoms of ADPA and ADPAca. 2. Differentiate ADPA from ADPAca. 3. Discuss the immunocytochemistry of ADPA and ADPAca. CME Test on page 210. This article has been peer reviewed and Medicine is accredited by the ACCME to provide approved by Michael Fisher, MD, Professor of continuing medical education for physicians. Medicine, Albert Einstein College of Medicine. Albert Einstein College of Medicine designates Review date: February 2002. this educational activity for a maximum of 1.0 hour This activity has been planned and implemented in category 1 credit toward the AMA Physician’s in accordance with the Essential Areas and Policies Recognition Award. Each physician should claim of the Accreditation Council for Continuing Medical only those hours of credit that he/she actually spent Education through the joint sponsorship of Albert in the educational activity. Einstein College of Medicine and Quadrant This activity has been planned and produced in HealthCom, Inc. The Albert Einstein College of accordance with ACCME Essentials. Aggressive digital papillary adenoma (ADPA) and rule out a possible risk of metastatic carcinoma adenocarcinoma (ADPAca) are adnexal tumors of the skin. Recognition of these tumors is impor- that are not often recognized because of their tant because of a potential risk of local recurrence rarity.
    [Show full text]
  • 第32回日本皮膚病理組織学会学術大会 診断投票結果 口演 1 Drug Eruption 13, うち Erythema Multif
    第32回日本皮膚病理組織学会学術大会 診断投票結果 口演 1 Drug eruption 13, うち erythema multiforme 1, Interface dermatitis 1, GVHD type 1 Cutaneous reaction due to CCR4 3, うち Dysplastic epidermal hyperplasia 2, Adverse reaction 1 Erythema multiforme 3 PLEVA 1 Vacuolar type interface dermatitis 1 口演 2 Syringofibroadenoma 15, うち + amyloid 1 Syringofibroadenoma with BCC 5 Basal cell carcinoma 4, うち Pinkus type of BCC with syringofibroadenoma 2 口演 3 Darier disease 5 Hailey-Hailey disease 4 Pemphigus 3, うち Pemphigus Vegetans 1, Neonatal pemphigus 1 Grover's disease 4 Epidermal nevus 5, うち Acantholytic (dyskeratotic) epidermal nevus 4, Linear epidermal nevus 1 口演 4 Hydradenoma 13, うち Clear cell hidradenoma 12, Nodular hidradenoma 1 Sebaceous adenoma 1 Trichilemmoma 1 Metastatic tumor 8, うち ~ renal carcinoma6, ~ Clear cell carcinoma 2 口演 5 Apocrine carcinoma 3, うち ~with pagetoid spreading 2 Ectopic breast carcinoma(invasive ductal type)with pagetoid phenomenon 2 Extramammary Paget's disease 12, うち Paget carcinoma 3, ~ with Apocrine adenoma 2, ~ with Tubular adenoma 1, Invasive ~ 1, +Skin metastasis 1, With syringoma 1, with Microcystic Adnexal Carcinoma 1 Syringomatous carcinoma 2, うち ~with paget phenomenon 1 Tubular adenocartinoma 1 Tubular (apocrine) adenoma 2 Syringoma 1 口演 6 Dermatofibroma 10, うち Lipidized ~ 3, Hemosiderotic deep cellular ~ 2, Xanthomatous ~ 1, ~ Histiocytoid variant 1 Fibous histiocytoma 8, うち Atypical ~ 3, Malignant ~ 2, Aneurismal ~ 2 Undifferentiated pleomorphic sarcoma 2 Progressive nodular histiocytosis 1 Squamous
    [Show full text]
  • An Institutional Experience
    Original Research Article Skin Adnexal Tumors- An Institutional Experience 1 2* 3 4 5 6 Rekha M Haravi , Roopa K N , Priya Patil , Rujuta Datar , Meena N Jadhav , Shreekant K Kittur 1,5Associate Professor, 2Post Graduate Student, 3,4Assistant Professor, 6Professor & HOD, Department of Pathology, Belgaum Institute of Medical Sciences Dr B R Ambedkar Road, Belagavi, Karnataka – 590001, INDIA. Email: [email protected] Abstract Background: Skin adnexal tumors are a wide spectrum of benign and malignant tumors that differentiate towards one or more adnexal structures found in normal skin. The adnexal structures of skin are the hair follicles, sebaceous glands, eccrine and apocrine sweat glands. These skin adnexal tumors are often difficult to diagnose clinically. This retrospective study was undertaken to know the various histomorphological patterns of skin adnexal tumors at our institution and to determine the incidence among the genders and age groups along with the site distribution. Materials and methods: A total of 40 specimens received and diagnosed as skin adnexal tumors in the department of Pathology at Belgaum Institute of Medical Sciences, Belagavi for a period of 6 years from January 2014 to December 2019 were taken for the study. Histopathological slides prepared from tissue blocks retrieved from departmental archives were reviewed and classified according to the WHO classification 2017. Results: Out of the total 40 samples, benign tumors were 36 (90%) and malignant were 4 (10%). Largest group was the benign tumors of apocrine and eccrine differentiation (47.5%) followed by benign tumors of hair follicle differentiation (40%). Malignant tumors of sebaceous differentiation were 5%, malignant tumors of eccrine and apocrine differentiation were 2.5% and malignant hair follicle differentiation tumors were 2.5% of the total.
    [Show full text]
  • Eyelid Conjunctival Tumors
    EYELID &CONJUNCTIVAL TUMORS PHOTOGRAPHIC ATLAS Dr. Olivier Galatoire Dr. Christine Levy-Gabriel Dr. Mathieu Zmuda EYELID & CONJUNCTIVAL TUMORS 4 EYELID & CONJUNCTIVAL TUMORS Dear readers, All rights of translation, adaptation, or reproduction by any means are reserved in all countries. The reproduction or representation, in whole or in part and by any means, of any of the pages published in the present book without the prior written consent of the publisher, is prohibited and illegal and would constitute an infringement. Only reproductions strictly reserved for the private use of the copier and not intended for collective use, and short analyses and quotations justified by the illustrative or scientific nature of the work in which they are incorporated, are authorized (Law of March 11, 1957 art. 40 and 41 and Criminal Code art. 425). EYELID & CONJUNCTIVAL TUMORS EYELID & CONJUNCTIVAL TUMORS 5 6 EYELID & CONJUNCTIVAL TUMORS Foreword Dr. Serge Morax I am honored to introduce this Photographic Atlas of palpebral and conjunctival tumors,which is the culmination of the close collaboration between Drs. Olivier Galatoire and Mathieu Zmuda of the A. de Rothschild Ophthalmological Foundation and Dr. Christine Levy-Gabriel of the Curie Institute. The subject is now of unquestionable importance and evidently of great interest to Ophthalmologists, whether they are orbital- palpebral specialists or not. Indeed, errors or delays in the diagnosis of tumor pathologies are relatively common and the consequences can be serious in the case of malignant tumors, especially carcinomas. Swift diagnosis and anatomopathological confirmation will lead to a treatment, discussed in multidisciplinary team meetings, ranging from surgery to radiotherapy.
    [Show full text]
  • A Rare Clinical Presentation of Desmoplastic Trichilemmoma
    Revista5Vol89ingles_Layout 1 8/8/14 10:17 AM Página 796 796 CASE REPORT s A rare clinical presentation of Desmoplastic Trichilemmoma mimicking Invasive Carcinoma* Daniela Tiemi Sano1 Jeane Jeong Hoon Yang1 Antonio José Tebcherani1 Luiz Arthur de Paula Machado Bazzo1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20143095 Abstract: Trichilemmoma is a benign neoplasm from the outer sheath of the pilosebaceous follicle. Desmoplastic trichilemmoma, a rare variant, is histologically characterized by a central area of desmoplasia that can clinically mimic an invasive carcinoma, requiring histopathological examination to define the diagnosis. Keywords: Hair diseases; Hair follicle; Skin neoplasms INTRODUCTION The trichilemmoma is a benign solid tumor ori- ma, without the presence of malignant processes, and ginating from external sheath cells of pilosebaceous associated with nevus sebaceous of Jadassohn in the follicles, and the desmoplastic trichilemmoma is a rare periphery of the lesion (Figures 3, 4, 5 and 6). Patient benign histological variant.1,2,3 Clinically, it may look is still under outpatient follow-up, with good clinical like other cutaneous lesions.2 Among the differential evolution and no relapse of lesion. diagnoses, we can cite basal-cell carcinoma, squamous cell carcinoma and viral lesions; the histopathological DISCUSSION examination is necessary for diagnostic confirmation. The trichilemmoma is a benign tumor origina- We report here a case of desmoplastic trichilemmoma ting from external root sheath cells of pilosebaceous in a
    [Show full text]
  • Pdf 344.65 K
    Differential Diagnosis of Basal Cell Carcinoma and Benign Tumors of Hair Follicles Using CD34 RESEARCH COMMUNICATION Differential Diagnosis of Basal Cell Carcinoma and Benign Tumors of Cutaneous Appendages Originating from Hair Follicles by Using CD34 Demet Sengul1, Ilker Sengul2*, Muzeyyen Hesna Astarci3, Huseyin Ustun3, Gamze Mocan4 Abstract Background and Aims: Differential diagnosis of the group of benign trichoblastomas, trichofolliculomas, trichoadenomas and trichoepitheliomas, and basal cell carcinomas (BCCs) is troublesome for the clinician as well as the pathologist, especially when only small biopsy specimens are available. Here we investigated whether CD34 expression might be of assistance. Methods: Thirty benign tumors of cutaneous appendages originating from hair follicles (BTCOHF) and 30 BCCs were retrieved from our archives and immunohistochemically stained. CD 34 expression was graded from [0] to [2+] and compared among the groups and subgroups. Results: There was no significant difference between the degree of expression between [0] and [1+] and [0] and [2+] for each group. However, [1+] and [2+] immunopositivity of BTCOHFs was significantly stronger than in BCCs (p= 0.014). Conclusions: CD34 may contribute to differential diagnosis of skin lesions. Keywords: Basal cell cancer - hair follicle lesions - CD 34 immunohistochemistry Asian Pacific J Cancer Prev, 11, 1615-1619 Introduction in 1958. TAs occur as a nodular lesion usually on the face and buttocks (Rahbari et al., 1977, Swaroop et al., 2008) Ackerman et al classified benign tumors of cutaneous and have a variant of verrucous TA mimicing seboreic appendages originating from hair follicle (BTCOHF)’s keratosis. using eight textbooks of dermatopathology in 2001 as Trichoepithelioma (TE) is a benign skin tumor with germ tumors of hair follicle and hamartomas, infindubular follicular differentiation determined in the classification and isthmic tumors, tumors of external layer, tumors of WHO as the synonym of TB (Cotton, 1991).
    [Show full text]
  • Histopathology of Dermal Adnexal Tumours - a Four Years Study
    International Journal of Science and Research (IJSR) ISSN (Online): 2319-7064 Index Copernicus Value (2013): 6.14 | Impact Factor (2015): 6.391 Histopathology of Dermal Adnexal Tumours - A Four Years Study Mukund Dhokiya1, Dr. Hemlata Talwelkar2, Dr. Sanjay Talwelkar3 13rd year Postgraduate Student, PDU Medical College & Hospital, Rajkot, India 2DA, MBBS, PDU Medical College & Hospital, Rajkot, India 3MD Pathology, Associate Professor, PDU Medical College & Hospital, Rajkot, India Abstract: Background: Dermal adnexal tumours (DAT) are a large and diverse group of benign and malignant tumours which exhibit morphological differentiation towards one of the different types of adnexal tumours present in normal skin: pilosebaeceous unit, eccrine and apocrine. Methods: 50 cases of skin adnexal tumours diagnosed in histopathological study over a period of 4 years (May 2012 to September 2016) in the Department of Pathology, PDU Medical College, Rajkot. Histopathological study is done in Formalin fixed, Paraffin embedded tissue sections stained with Haematoxylin and Eosin. Results: Skin adnexal tumours found most common in the age group of 21 to 60 years (74%, 37/50). Male to female ratio was 1:1.2. 98% cases found benign with only a single case (2%) malignant. The sweat gland tumors formed the largest group involving 52% of cases followed by hair follicle tumors (40%),sebaceous gland tumours (6%) and mixed (2%). Nodular hidradenoma (22%) and trichilemmal cyst (22%) found the most common benign tumours. Chondroid syringoma with malignant changes is the only malignant adnexal tumour reported in our study. Conclusion: Dermal adnexal tumours are relatively rare. Benign adnexal tumors are far more common than their malignant counterparts.
    [Show full text]
  • Inherited Skin Tumour Syndromes
    CME GENETICS Clinical Medicine 2017 Vol 17, No 6: 562–7 I n h e r i t e d s k i n t u m o u r s y n d r o m e s A u t h o r s : S a r a h B r o w n , A P a u l B r e n n a n B a n d N e i l R a j a n C This article provides an overview of selected genetic skin con- and upper trunk. 1,2 These lesions are fibrofolliculomas, ditions where multiple inherited cutaneous tumours are a cen- trichodiscomas and acrochordons. Patients are also susceptible tral feature. Skin tumours that arise from skin structures such to the development of renal cell carcinoma, lung cysts and as hair, sweat glands and sebaceous glands are called skin pneumothoraces. 3 appendage tumours. These tumours are uncommon, but can Fibrofolliculomas and trichodiscomas clinically present as ABSTRACT have important implications for patient care. Certain appenda- skin/yellow-white coloured dome shaped papules 2–4 mm in geal tumours, particularly when multiple lesions are seen, may diameter (Fig 1 a and Fig 1 b). 4 These lesions usually develop indicate an underlying genetic condition. These tumours may in the third or fourth decade.4 In the case of fibrofolliculoma, not display clinical features that allow a secure diagnosis to be hair specific differentiation is seen, whereas in the case of made, necessitating biopsy and dermatopathological assess- trichodiscoma, differentiation is to the mesodermal component ment.
    [Show full text]
  • Cancer Immunoprevention: a Case Report Raising the Possibility of “Immuno-Interception” Jessica G
    CANCER PREVENTION RESEARCH | RESEARCH BRIEF Cancer Immunoprevention: A Case Report Raising the Possibility of “Immuno-interception” Jessica G. Mancuso1, William D. Foulkes1,2,3, and Michael N. Pollak1,2 ABSTRACT ◥ Immune checkpoint blockade therapy provides substan- or neoplastic lesions over a period of 19 years (mean tial benefits for subsets of patients with advanced cancer, 7.5 neoplasms/year, range 2–26) prior to receiving but its utility for cancer prevention is unknown. Lynch pembrolizumab immunotherapy as part of multi- syndrome (MIM 120435) is characterized by defective modality treatment for invasive bladder cancer. He not DNA mismatch repair and predisposition to multiple only had a complete response of the bladder cancer, but cancers. A variant of Lynch syndrome, Muir–Torre also was noted to have an absence of new cancers during a syndrome (MIM 158320), is characterized by frequent 22-month follow-up period. This case adds to the rationale gastrointestinal tumors and hyperplastic or neoplastic skin for exploring the utility of immune checkpoint blockade tumors. We report the case of a man with Muir–Torre forcancerprevention,particularlyforpatientswithDNA syndrome who had 136 cutaneous or visceral hyperplastic repair deficits. Introduction There is an obvious clinical need to reduce cancer incidence in patients with DNA repair deficits, and prophylactic surgery The clinically demonstrated utility of antiviral vaccines to is commonly employed. Clinical trials designed to evaluate reduce risk of virally initiated cancers represents a major strategies to reduce cancer incidence are challenging: in popu- success in cancer immunoprevention. There is interest in the lations where baseline risk is low, a large number of subjects and possibility that immunoprevention may also be useful where long follow-up periods are required.
    [Show full text]
  • The Best Diagnosis Is: H&E, Original Magnification 2
    Dermatopathology Diagnosis The best diagnosis is: H&E, original magnification 2. a. adenoid cysticcopy carcinoma arising within a spiradenoma b. cylindroma and spiradenoma collision tumor c. microcysticnot change within a spiradenoma d. mucinous carcinoma arising within a spiradenoma Doe. trichoepithelioma and spiradenoma collision tumor CUTIS H&E, original magnification 100. PLEASE TURN TO PAGE 211 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Amanda F. Marsch, MD; Jeffrey B. Shackelton, MD; Dirk M. Elston, MD Dr. Marsch is from the Department of Dermatology, University of Illinois at Chicago. Drs. Shackelton and Elston are from the Ackerman Academy of Dermatopathology, New York, New York. The authors report no conflict of interest. Correspondence: Amanda F. Marsch, MD, University of Illinois at Chicago, 808 S Wood St, Chicago, IL 60612 ([email protected]). 192 CUTIS® WWW.CUTIS.COM Copyright Cutis 2015. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Dermatopathology Diagnosis Discussion Trichoepithelioma and Spiradenoma Collision Tumor he coexistence of more than one cutaneous adnexal neoplasm in a single biopsy specimen Tis unusual and is most frequently recognized in the context of a nevus sebaceous or Brooke-Spiegler syndrome, an autosomal-dominant inherited disease characterized by cutaneous adnexal neoplasms, most commonly cylindromas and trichoepitheliomas.1-3 Brooke-Spiegler syndrome is caused by germline muta- tions in the cylindromatosis gene, CYLD, located on band 16q12; it functions as a tumor suppressor gene and has regulatory roles in development, immunity, and inflammation.1 Weyers et al3 first recognized the tendency for adnexal collision tumors to present in patients with Brooke-Spiegler syndrome; they reported a patient with Brooke-Spiegler syndrome with spirad- Figure 1.
    [Show full text]